Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
10/2003
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203879 For enhancing magnetic resonance imaging (MRI); nuclear magnetic resonance
10/30/2003US20030203877 Such as dipyroxylamine; for treating and preventing chronic tissue damage and diabetic complications (dialysis-related pathologies, proteinuria, impaired glomerular clearance, diabetic nephropathy, and protein crosslinking)
10/30/2003US20030203852 Acyl pseudodipeptides which carry a functionalised auxialiary arm
10/30/2003US20030201161 Complex of ligand and transition metal compound; forming hydrogen from hydrogen halide solution
10/29/2003EP1357134A2 Catalyst compositions for the polymerization of olefins
10/29/2003EP1357126A1 Method of assaying lysophospholipase d activity
10/29/2003EP1355956A2 Polymerization of olefinic compounds
10/29/2003EP1355912A1 Ligands and their use
10/29/2003EP1355855A1 Processes for treating coral and coating an object
10/29/2003EP1112256B1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
10/29/2003EP1004588B1 Process for producing phosphoric ester compounds
10/29/2003EP0970095B1 Novel benzimidazole inhibitors of fructose-1,6-bisphosphatase
10/29/2003CN1451686A Flame-retardant processing agent, flame-retardant processing method and flame-retardant processed product
10/29/2003CN1451685A Polymer flame retardant of mixture contg. two different aryl phosphates, method for preparing same and use thereof
10/29/2003CN1125818C Amino acid derivatives of substituted quinexaline 2,3-dione derivatives as glutamate receptor antagonists
10/29/2003CN1125807C Excitatory amino acid receptor modulators
10/28/2003US6639114 Hydroformylation catalyst comprising a complex with ligands having a structure derived from bisphenol A
10/28/2003US6639091 Diphosphine or dimetal; with a polysubstituted aliphatic bridging group; results in a high regioselectivity towards the linear product and/or higher activity
10/28/2003US6639023 Fluorophenyl resin compounds
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638933 Bicyclic imidazo-3-yl-amine derivatives
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638921 Pyridoxal-5-phosphate derivatives as HIV integrase inhibitors
10/28/2003US6638919 Antiviral purine derivatives
10/25/2003CA2383390A1 Easily removalbe reagents for the mitsunobu reaction
10/23/2003WO2003087298A2 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/23/2003WO2003087130A2 Process for manufacturing purified phosphorodiamidite
10/23/2003WO2003087113A1 Method for the production of perfluoroalkyl phosphines and the use thereof as perfluoroalkylating reactants
10/23/2003WO2003087112A1 Chiral intermediate and process for the production thereof
10/23/2003WO2003087111A1 Method for the production of monohydro-perfluoroalkanes, bis(perfluoroalkyl)phosphinates, and perfluoroalkylphosphonates
10/23/2003WO2003087110A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003WO2003087109A1 Medicaments containing glycerophosphoinositol-4-phosphate derivatives
10/23/2003WO2003087108A2 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087040A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003WO2003087028A1 A method of making salt
10/23/2003WO2003087026A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003WO2003087025A1 Method for producing ethers, esters or acid anhydrides
10/23/2003WO2003087020A1 Method for perfluoroalkylation by means of tris(perfluoroalkyl)phosphine oxides
10/23/2003WO2003086605A2 Functionalized ionic liquids, and methods of use thereof
10/23/2003WO2003086414A1 Structural modification of resveratrol: sodium resverastatin phosphate
10/23/2003WO2003086384A1 Stabilized ascorbic acid derivatives
10/23/2003WO2003086355A1 Novel polymorphs and pseudopolymorphs of risedronate sodium
10/23/2003WO2003086318A2 Improved prodrugs of cc-1065 analogs
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003US20030199713 Catalyst for asymmetric (transfer) hydrogenation
10/23/2003US20030199712 Hydrolysis and halogenation of ester of 2-substitued imino-3-methyloxo-butyric acid by photochemical irradiation in one pot using a halogenting agent to form 4-halogeno-2-substituted imino-3-oxo-butyric acid
10/23/2003US20030199704 Reacting a Group VA metal trihalide with a reagent selected from an (C1-C10)alkyl lithium compound and a compound RnM1X3-n wherein each R is (C1-C10)alkyl, M1 is a Group IIIA metal, X is halogen, n=1-3 , in an organic solvent
10/23/2003US20030199691 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003US20030199619 Reducing volatile organic compound emissions while making the sulfur vulcanized rubber
10/23/2003US20030199533 Administering amino, carboxy, alkyl derivatives of barbituric acid to treat diseases of the central nervous system related to the metabotropic glutamate receptor system
10/23/2003US20030199519 Prodrugs of CC-1065 analogs
10/23/2003US20030199084 Chemoselective ligation
10/23/2003US20030198663 Phospholipid-analogous compounds
10/23/2003CA2482656A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
10/23/2003CA2482544A1 2-(2,6-dichlorophenyl)-diarylimidazoles
10/23/2003CA2481222A1 Method for producing ethers, esters or acid anhydrides
10/23/2003CA2481202A1 Functionalized ionic liquids, and methods of use thereof
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2480764A1 Novel polymorphs and pseudopolymorphs of resedronate sodium
10/23/2003CA2480759A1 Improved prodrugs of cc-1065 analogs
10/23/2003CA2480415A1 Mimics of acyl coenzyme-a, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480410A1 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
10/23/2003CA2480359A1 Process for manufacturing purified phosphorodiamidite
10/23/2003CA2466301A1 Nucleosides preparation thereof and use as inhibitors of rna viral polymerases
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1354886A1 Process for the preparation of tertiary phosphines
10/22/2003EP1354885A1 Flame retardants for polymers comprising a mixture of two different aryl phoaphates, their preparation and use thereof
10/22/2003EP1353930A1 Method for producing n-phosphonomethyl iminodiacetic acid
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/22/2003EP1140745B1 Colchinol derivatives as vascular damaging agents
10/22/2003EP1056754B1 Phosphate derivatives of diaryl 1,3,4-oxadiazolone
10/22/2003EP0699069B9 Endothelin receptor antagonists
10/22/2003CN1451012A Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
10/22/2003CN1451011A 7-acylamino-3-heteroarylthio-3-cephem carboxylic and prodrugs thereof
10/22/2003CN1450990A Inhibitors of neuraminidases
10/22/2003CN1450989A 7-substituted tetracycline compounds
10/22/2003CN1450915A Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
10/22/2003CN1450072A Storage of phosphonium phenolate catalysts and their use as interesterification catalysts
10/22/2003CN1450071A Synthesis and use of novel thorium color developing reagent metafluoro azo fluorophosphine
10/22/2003CN1450032A Compound with base skeleton of 1,6-methylene-[10]-annulene and use thereof
10/22/2003CN1125066C Tetrahydrofuran phosphate-and hydroxy esters as prodrugs for corresponding antifungal agent
10/22/2003CN1124846C (N.N')-bis (sulfonyl) hydrazines useful as antineoplastic agents
10/21/2003US6635784 Process for the preparation of enantiomerically-enriched cyclopropylalanine derivates
10/21/2003US6635630 Respiratory system disorders; antiinflammatory agents
10/21/2003US6635618 Glycopeptide phosphonate derivatives
10/21/2003US6635437 Useful in methods for producing light and in assays for phosphatase enzymes and enzyme inhibitors and in assays employing enzyme-labeled specific binding pairs
10/21/2003CA2235905C Olefin polymerization catalysts, transition metal compounds, processes for olefin polymerization, and .alpha.-olefin/conjugated diene copolymers
10/21/2003CA2208714C Bone mass anabolic composition comprising olpadronate
10/16/2003WO2003084973A1 Metal complexes and organic electroluminescent devices
10/16/2003WO2003084971A1 Bisphosphines as bidentate ligands
10/16/2003WO2003070169A3 Aminodiphosphonate apolipoprotein e modulators
10/16/2003WO2003062171A3 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
10/16/2003WO2003027314A3 Protected linker compounds
10/16/2003WO2002098549A3 Compositions of alkanolamine salts of alkyl phosphate esters
10/16/2003WO2002092024A3 Compounds and methods for inhibiting axillary malodour
10/16/2003WO2002059243A3 Zwitterionic gemini surfactants for use in carbon dioxide
10/16/2003US20030195378 Method for hydroformylation, xanthene-bridged ligands and catalyst comprising a complex of said ligands
10/16/2003US20030195369 Optically active chiral diphosphine ligands
1 ... 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 ... 554